S100A8 and necrotizing enterocolitis: Another issue that needs to be pointed out is the absence of the calprotectin S100A8 and 100A9 components and lipocalin-2 (LCN2) in the final list of selected proteins, considering that they were previously identified as a robust stool biomarker combination for predicting more than half of the NEC infants [35].